Skip to main content

Delivery of glycoprotein IIb/IIIa inhibitor therapy for percutaneous coronary intervention: why not take the intracoronary highway?

Publication ,  Journal Article
Gurbel, PA; Tantry, US
Published in: Circulation
February 16, 2010

Duke Scholars

Published In

Circulation

DOI

EISSN

1524-4539

Publication Date

February 16, 2010

Volume

121

Issue

6

Start / End Page

739 / 741

Location

United States

Related Subject Headings

  • Platelet Glycoprotein GPIIb-IIIa Complex
  • Platelet Aggregation Inhibitors
  • Peptides
  • Humans
  • Eptifibatide
  • Embolism
  • Cardiovascular System & Hematology
  • Angioplasty, Balloon, Coronary
  • Acute Coronary Syndrome
  • 4207 Sports science and exercise
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Gurbel, P. A., & Tantry, U. S. (2010). Delivery of glycoprotein IIb/IIIa inhibitor therapy for percutaneous coronary intervention: why not take the intracoronary highway? Circulation, 121(6), 739–741. https://doi.org/10.1161/CIR.0b013e3181d40dc9
Gurbel, Paul A., and Udaya S. Tantry. “Delivery of glycoprotein IIb/IIIa inhibitor therapy for percutaneous coronary intervention: why not take the intracoronary highway?Circulation 121, no. 6 (February 16, 2010): 739–41. https://doi.org/10.1161/CIR.0b013e3181d40dc9.
Gurbel, Paul A., and Udaya S. Tantry. “Delivery of glycoprotein IIb/IIIa inhibitor therapy for percutaneous coronary intervention: why not take the intracoronary highway?Circulation, vol. 121, no. 6, Feb. 2010, pp. 739–41. Pubmed, doi:10.1161/CIR.0b013e3181d40dc9.

Published In

Circulation

DOI

EISSN

1524-4539

Publication Date

February 16, 2010

Volume

121

Issue

6

Start / End Page

739 / 741

Location

United States

Related Subject Headings

  • Platelet Glycoprotein GPIIb-IIIa Complex
  • Platelet Aggregation Inhibitors
  • Peptides
  • Humans
  • Eptifibatide
  • Embolism
  • Cardiovascular System & Hematology
  • Angioplasty, Balloon, Coronary
  • Acute Coronary Syndrome
  • 4207 Sports science and exercise